Influenza is the cause of significant morbidity and mortality in pediatric populations. The contribution of pulmonary host defense mechanisms to viral respiratory infection susceptibility in very young children is poorly understood. As a surrogate to compare mucosal immune responses of infant and adult lungs, rhesus monkey primary airway epithelial cell cultures were infected with pandemic influenza A/H1N1 virus in vitro. Virus replication, cytokine secretion, cell viability, and type I interferon (IFN) pathway PCR array profiles were evaluated for both infant and adult cultures. In comparison with adult cultures, infant cultures showed significantly increased levels of H1N1 replication, reduced alpha interferon (IFN-␣) protein synthesis, and no difference in cell death following infection. Age-dependent differences in expression levels of multiple genes associated with the type I IFN pathway were observed in H1N1-infected cultures. To investigate the pulmonary and systemic responses to H1N1 infection in early life, infant monkeys were inoculated with H1N1 by upper airway administration. Animals were monitored for virus and parameters of inflammation over a 14-day period. High H1N1 titers were recovered from airways at day 1, with viral RNA remaining detectable until day 9 postinfection. Despite viral clearance, bronchiolitis and alveolitis persisted at day 14 postinfection; histopathological analysis revealed alveolar septal thickening and intermittent type II pneumocyte hyperplasia. Our overall findings are consistent with the known susceptibility of pediatric populations to respiratory virus infection and suggest that intrinsic developmental differences in airway epithelial cell immune function may contribute to the limited efficacy of host defense during early childhood.
IMPORTANCE
To the best of our knowledge, this study represents the first report of intrinsic developmental differences in infant airway epithelial cells that may contribute to the increased susceptibility of the host to respiratory virus infections. Despite the global burden of influenza, there are currently no vaccine formulations approved for children <6 months of age. Given the challenges of conducting experimental studies involving pediatric patients, rhesus monkeys are an ideal laboratory animal model to investigate the maturation of pulmonary mucosal immune mechanisms during early life because they are most similar to those of humans with regard to postnatal maturation of the lung structure and the immune system. Thus, our findings are highly relevant to translational medicine, and these data may ultimately lead to novel approaches that enhance airway immunity in very young children.
I
nfluenza remains a significant health threat for pediatric populations. The Centers for Disease Control and Prevention estimates that 20,000 children under the age of 5 years are hospitalized each year due to influenza-related illnesses (1, 2) . During the 2009 H1N1 pandemic, children showed an increased risk of severe outcomes and a higher death rate than that of previous influenza seasons (3-7). We currently lack licensed vaccines and antiviral drugs for children Ͻ6 months of age, and traditional inactivated vaccines for school-aged children show limited efficacy (8, 9) . A better understanding of the mucosal immune response to influenza virus infection in young children is necessary to identify specific deficiencies in young hosts and elucidate adjunctive methods for improving pediatric immunity against all respiratory pathogens.
Although the infant immune system provides some protection against infectious disease, its ability to mount a robust response to respiratory pathogens is limited (10) (11) (12) (13) . The reduced functional capacity of the infant immune system has been attributed to deficiencies in several immune cells, including T lymphocytes, B lymphocytes, and antigen-presenting cells (14) (15) (16) (17) (18) . Circulating T cells and antigen-presenting cells in infants are impaired in a range of effector functions from cellular activation to cytokine production (11, 13, (19) (20) (21) (22) (23) .
Airway epithelial cells play a central role in host immunity to respiratory pathogens, providing the first line of defense and regulating adaptive immune responses (24) . A unique feature of primate species is the presence of a prolonged period of postnatal lung development, during which airway epithelial cells continue to mature and differentiate (25) (26) (27) . In humans, levels of antimicrobial receptors and defensins in the airway epithelium have been shown to increase from birth through preschool age (18, 28, 29) , and dramatic differences in endotoxin responsiveness have been demonstrated for infant compared to adult intestinal epithelial cells (30) . We have recently reported that innate immune responses to endotoxin in the nonhuman primate airway epithelium are also variable with age (31) . Collectively, these data suggest that chronological age can impact the immune response elicited by lung mucosa in infant versus adult hosts.
The mechanisms underlying the development of immune competency in human infant lungs are not well understood due to challenges and ethical concerns involved in studying pediatric patients. Thus, our understanding of mucosal immunity in early life has been acquired primarily through studies of human cord blood and neonatal rodents. Because the interconnected maturation of pulmonary and immune systems in humans is distinct from that of rodents, it is critical to address translational questions associated with the development of lung immunity in a primate species (32, 33) . In this study, we hypothesized that intrinsic functional differences in infant respiratory mucosa contribute to enhanced susceptibility to influenza virus infection. This hypothesis was tested by conducting infection studies with the pandemic influenza virus A/H1N1 strain in primary airway epithelial cell cultures derived from infant and adult rhesus monkeys. To compare the in vitro infant airway epithelial cell responses to infection with in vivo airway responses, we assessed pulmonary and systemic responses following inoculation of the pandemic influenza virus A/H1N1 strain in infant rhesus monkeys. In vitro H1N1 infection. Infant (Ͻ12 months of age) and adult (Ͼ3 years of age) rhesus monkey tracheobronchial tissues were obtained from the California National Primate Research Center Pathology Unit. Primary airway epithelial cells were cultured on transwell inserts (Corning, Corning, NY) under air-liquid interface (ALI) conditions, as previously described (31) . The apical surface of individual ALI culture wells was inoculated with 150 l H1N1 influenza virus in ALI medium with 1 g/ml trypsin at a multiplicity of infection (MOI) of 0, 0.1, 1, or 10. In addition, an inoculum at an MOI of 1 was UV inactivated as a control. The inoculum was removed from ALI culture wells after 1 h, and the apical epithelial cell surface was washed with sterile phosphate-buffered saline (PBS) (Sigma-Aldrich Corp.). ALI cultures were subsequently maintained for 6 to 96 h.
MATERIALS AND METHODS

Virus
For poly(I·C) stimulations, the Toll-like receptor 3 ligand was diluted in ALI medium to a concentration of 10 g/ml, and 100 l was then applied to the apical surface. The stimulation medium was removed after 1 h, and cells were maintained in culture for 24 h.
Metabolic activity was measured with alamarBlue (Invitrogen/Life Technologies, Carlsbad, CA), which was diluted directly into the basolateral ALI medium of cultures with ϳ16-h incubations at 37°C in 5% CO 2 . Fluorescence was read by using an excitation wavelength of 540 to 570 nm and an emission wavelength of 580 to 610 nm, according to the manufacturer's recommendations. Nonviable cells generate a lower fluorescence signal than healthy cells, and results were reported relative to those for age-matched, mock-infected controls for each time point.
In vivo H1N1 infection. Infant rhesus macaque monkeys between 6 and11 months of age were inoculated with 1 ϫ 10 8 50% tissue culture infective doses (TCID 50 ) of H1N1 influenza A virus (n ϭ 5) or control medium (n ϭ 3) by intranasal and intratracheal instillation in a 1-ml total volume at day 0. While animals were under ketamine anesthesia, the nasal cavity was lavaged with 2 ml of PBS (Sigma-Aldrich, St. Louis, MO), and trachea samples were obtained with a Mini-Tip BD Culturette swab (BD Biosciences, San Jose, CA) that was inserted with the aid of a laryngoscope. Nasal lavage fluid, pharyngeal swab samples, trachea swab samples, and peripheral blood were collected on days Ϫ4, 1, 2, 3, 7, 9, 11, and 14 of infection. Rectal temperature was measured at each collection time point. All animals were seronegative for hemagglutinin-inhibiting antibodies to H1N1 influenza virus prior to the initiation of the study. Bronchoalveolar lavage fluid specimens were obtained at the time of necropsy by cannulation of the right caudal lung lobe and inflation with 20 ml sterile PBS. Care and housing of animals complied with the provisions of the Institute of Laboratory Animal Resources and conformed to practices established by the American Association for Accreditation of Laboratory Animal Care.
H1N1 virus quantitation. Viral titers were determined by TCID 50 assays on MDCK cells according to the method of Reed and Muench (34) . Samples were incubated for 24 h, followed by visualization of influenza virus-infected cells by immunocytochemistry using an anti-influenza A virus nucleoprotein clone A1 and A3 blend (Millipore, Billerica, MA) and using 3=,3=-diaminobenzidine (Vector Laboratories, Burlingame, CA). RNA isolation and analysis. Cells were harvested in TRIzol reagent (Invitrogen), and reverse transcription was performed on total RNA extracted with random hexamer primers and MultiScribe reverse transcriptase (Applied Biosystems). mRNA levels of interleukin-8 (IL-8), alpha 6 interferon (IFN-␣6), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were measured by TaqMan real-time PCR using commercially available primer-probe sets (Applied Biosystems) and analyzed on an Applied Biosystems Prism 7900 sequence detection system. Progressive dilution of purified human cDNA plasmid constructs (Origene, Rockville, MD) for each gene target was used to generate standard curves for the absolute quantitation of mRNA copy numbers. All reagents were tested to confirm comparable detection of both rhesus and human targets.
For the IFN-␣/␤ PCR array (SABiosciences, Valencia, CA), airway epithelial cells were harvested in RLT buffer (Qiagen, Valencia, CA), and RNA was extracted according to the RNeasy minikit instructions. The RT2 first-strand kit was used to synthesize cDNA from 1,000 ng of RNA for use in a 96-well format, which was analyzed on a ViiA 7 real-time PCR system (Applied Biosystems). Analysis of the PCR array was conducted as previously reported, using RT2 PCR array online data analysis software, version 3.5 (31) .
Cytokine ELISA. IL-8 (eBiosciences, San Diego, CA) and IFN-␣ (panspecific; MABtech, Sweden) proteins were measured by enzyme-linked immunosorbent assays (ELISAs), according to the manufacturer's instructions. The limits of detection for ELISAs were 4 pg/ml (IL-8) and 7 pg/ml (IFN-␣).
Immunocytochemistry staining of airway epithelial cell cultures. For H1N1 immunostaining, epithelial cells on transwells were fixed with 10% phosphate-buffered formalin (Sigma-Aldrich Corp.) for 30 min. Endogenous peroxidase was blocked with 3% hydrogen peroxide for 1 h, followed by a nonspecific block with Western blot-grade nonfat dried milk for 30 min (Lab Scientific, Highlands, NJ). The primary anti-influenza A virus nucleoprotein clone A1 and A3 blend antibody (Millipore, Billerica, MA) was incubated overnight at 4°C. Incubation with horseradish peroxidase-conjugated secondary antibody (Life Technologies, Grand Island, NY) was followed by 3=,3=-diaminobenzidine substrate development. The immunostained transwell membrane was mounted onto a microscope slide and imaged on an Olympus BX61 microscope with an Olympus DP72 color camera. For cleaved caspase-3 immunofluorescent staining, the following modifications were made: transwells were blocked in immunograde bovine serum albumin (Sigma-Aldrich Corp.) and incubated with Image-It (Invitrogen/Life Technologies) prior to overnight incubation with the caspase-3 primary antibody (cleaved ASP175; Cell Signaling Technologies, Danvers, MA). A goat anti-rabbit Alexa 488 secondary antibody (Invitrogen/Life Technologies) was applied for 45 min.
Leukocyte differentials. Aliquots of lavage fluid and swab samples were cytocentrifuged, air dried, and stained with a modified Wright stain (Diff-Quik; Polysciences, Warrington, PA). The proportion of macrophages, monocytes, neutrophils, eosinophils, lymphocytes, and epithelial cells was determined by counting 300 cells per sample by light microscopy.
Histopathology. The left caudal and right cranial lung lobes of mockand influenza virus-infected infants were perfused via bronchial cannula for 1 h at 30-cm fluid pressure with 10% phosphate-buffered formalin (Sigma-Aldrich Corp.). The lung lobes were then processed and embedded in paraffin. Five-micrometer-thick paraffin sections were cut and stained with hematoxylin and eosin (H&E). Histopathology slides were read and scored by a board-certified veterinary pathologist. Images were obtained with an Olympus BX53 microscope mounted with an Olympus DP72 camera and Olympus CellSens software.
Pulmonary lesions were scored on a scale of 0 to 4, with a score of 0 indicating no lesions; 1 indicating minimal lesions, with inflammation centered on terminal bronchioles with little or no extension into the dependent alveoli; 2 indicating mild lesions, with inflammation centered on terminal bronchioles with some extension into the dependent alveoli; 3 indicating moderate lesions, with inflammation centered on terminal bronchioles with extension into the dependent alveoli accompanied by moderate alveolar epithelial injury and repair (large confluent lesions may be formed); and 4 indicating severe lesions, with extensive inflammation centered on terminal bronchioles and alveolar parenchyma with severe alveolar epithelial injury and repair resulting in extensive confluent lesions.
Statistics. Data are reported as means Ϯ standard errors of the means (SEM), unless otherwise noted. Time postinfection and age-dependent differences were evaluated for each infection condition separately by twoway analysis of variance (ANOVA) with multiple comparisons and a Holm-Sidak posttest. Unpaired two-tailed, parametric, or nonparametric t tests were also used where appropriate. GraphPad Prism 6.03 (GraphPad, La Jolla, CA) was used for statistical analysis. A P value of 0.05 or less was considered statistically significant.
RESULTS
Increased H1N1 replication in infant airway epithelial cell cultures.
Little is known about the immunological factors that contribute to heightened infection susceptibility in very young children. As an approach to compare the mucosal innate immune responses to viral infection in infant and adult monkeys, we conducted comparative H1N1 influenza virus A/CA/04/09 infections with live or UV-inactivated virus in primary airway epithelial cell ALI cultures derived from infant (Ͻ1 year of age) and adult (Ͼ3 years of age) rhesus monkeys. At an MOI of 1, levels of viral RNA and replicating virus measured in wash specimens from the apical surface were increased in infant ALI cultures relative to those of adults, with significantly higher H1N1 titers being detected at 48 and 96 h postinfection (by two-way ANOVA for age and time postinfection) ( Fig. 1D and E) . Levels of replication-competent virus fluctuated at between 24 and 96 h postinfection in infant cultures, whereas levels of virus recovered from adult cultures appeared to progressively decline after 24 h. No replicating virus was detected in cultures infected with UV-inactivated virus. Agespecific differences in replicating H1N1 levels but not viral mRNA levels were also observed during infection with a lower dose (MOI 0.1), resulting in significantly higher virus titers in infant than in adult cultures at 96 h postinfection (by two-way ANOVA for age and time postinfection) ( Fig. 1A and B ). Similar to infant cultures infected at an MOI of 1, infant cultures infected at an MOI of 0.1 varied in the levels of virus recovered throughout the infection period, whereas adult virus titers tended to decline from 24 to 96 h. H1N1 infection of infant and adult cultures at an MOI of 10 resulted in similar viral replication and mRNA levels between age groups, with little to no increase over the infection period ( Fig. 1G  and H) . At an MOI of 1, we also observed more H1N1 nucleoprotein immunostaining in infant ALI cultures than in cultures from adults ( Fig. 2) .
To determine if cell death had an impact on viral replication levels, viability assays were conducted using ALI cultures. Infant and adult airway epithelial cell cultures showed no significant difference in cell viability when infected with live or UV-inactivated virus (MOI of 1) at any time point from 6 to 96 h postinfection (Fig. 1F) . Immunostaining for the apoptosis marker cleaved caspase-3 showed more fluorescence-positive cells in H1N1-infected (MOI of 1) infant and adult epithelial cell cultures than in mock-infected controls, peaking at 6 h postinfection; overall, the cleaved-caspase-3 staining patterns were similar in H1N1-infected infant and adult cultures (Fig. 3) . There was also no clear trend for age-specific differences in cell viability for infection at an MOI of 0.1 (Fig. 1C) . However, in cultures infected at an MOI of 10, time was a significant source of variation, and age was near significance (P ϭ 0.08), for metabolic activity, which peaked at 72 h in adult cells (by two-way ANOVA for age and time postinfection) (Fig. 1I) .
Evaluation of the antiviral cytokine IFN-␣ revealed an increase in mRNA levels over those of mock-infected controls at 6 h postinfection in both infant and adult airway epithelial cell cultures infected with live or UV-inactivated virus at an MOI of 1 (Fig. 4A) . Infection-induced changes in IFN-␣ mRNA expression levels were lower at subsequent time points for both age groups, with no age-dependent differences being detected (by two-way ANOVA for age and time postinfection; live and UV-inactivated virus statistical tests were done separately). In contrast, age significantly impacted the secretion of IFN-␣ protein in basolateral media from H1N1-infected ALI cultures (by two-way ANOVA for time and age) (Fig. 4B ). Little to no induction of IFN-␣ protein was detected in H1N1-infected infant cultures relative to mockinfected cultures, whereas adult cultures showed increased levels above those of mock-infected controls by 6 h postinfection. The total IFN-␣ protein level in the basolateral medium peaked at 48 h postinfection in H1N1-infected cultures, with significantly lower levels in infants than in adults (by two-way ANOVA for age and time postinfection) (Fig. 5B) . No age-dependent difference in IFN-␣ mRNA or protein induction was detected in cultures infected with UV-inactivated virus. We also assessed the impact of age on IL-8 expression in ALI cultures; levels of induction of IL-8 mRNA for both live and UV-inactivated H1N1 infections were generally lower in infant than in adult cultures at most infection time points, but these differences did not reach statistical significance (by two-way ANOVA for age and time postinfection; live and UV-inactivated virus statistical tests were done separately) (Fig. 4C) . Similarly, the induction of IL-8 protein with H1N1 infection relative to mock infection did not vary significantly with age (by two-way ANOVA for age and time postinfection) (Fig.  4D) . Independent of infection status, IL-8 protein concentrations in the basolateral medium of infant cultures increased over the 96-h time course, whereas adult cultures showed minimal changes (by two-way ANOVA for age and time postinfection) (Fig. 5D) .
We also compared the cytokine responses to Toll-like receptor 3 ligand binding after 24 h following treatment with poly(I·C) in infant and adult airway epithelial cell ALI cultures (Fig. 6) . As with H1N1 infection, we detected transcription of IFN-␣ mRNA but no IFN-␣ protein induction with poly(I·C) treatment in infant cultures. This was in contrast to the robust IFN-␣ protein response to poly(I·C) observed in adult cultures (P Ͻ 0.05 by Student's t test for infants versus adults). IL-8 mRNA and protein were induced by poly(I·C) treatment in both infant and adult airway epithelial cell cultures, with no age-dependent differences being noted at 24 h posttreatment.
Targeted RT-PCR arrays for IFN-␣ and IFN-␤ pathways were used to further characterize the differential innate immune response to H1N1 infection in infant and adult primary airway epithelial cell ALI cultures. In mock-infected cultures, we observed multiple genes that were expressed at a Ͼ2-fold difference in adult versus infant cultures, although only the expression of MAL (myelin and lymphocyte protein) was found to be statistically significant (Table 1) . MAL encodes an epithelial cell membrane lipoprotein known to be involved in apical transport and was expressed at Ͼ5-fold-lower levels in infant than in adult airway epithelial cells. After 24 h of H1N1 infection, infant cultures showed significantly increased mRNA levels of CXCL10, OAS1, OAS2, ISG15, and the apoptotic genes IFI27 and PTTG1 relative to mock-infected controls; none of these genes showed significantly increased levels in H1N1-infected adult cultures (by Student's t tests) (Fig. 7) . For direct comparison of H1N1 infection-induced gene expression levels for IFN-␣ and IFN-␤ pathways in infant cultures relative to adult cultures, the levels of several genes, including CIITA, CASP1, and RPL13A, were significantly lower in infant cultures (by Student's t test) ( Table 1) . PTTG1 was the only gene that showed a significantly higher level in H1N1-infected infant cultures than in adult cultures. Many genes in the array showed no age-dependent differences in mock-or H1N1-infected epithelial cell cultures (see Tables S1 and S2 in the supplemental material).
H1N1 viral loads and clinical outcomes for infant monkeys. To assess infant susceptibility to H1N1 influenza virus infection in vivo, 6-to 11-month-old rhesus monkeys were inoculated with H1N1 A/California/04/09 (n ϭ 5) or control medium (n ϭ 3) by administration into upper airways. Animals were monitored longitudinally for viral replication, clinical symptoms, and inflammation over a 14-day infection time course. Replicating virus was recovered from nasal lavage fluid samples of all H1N1-infected animals at day 1 postinfection, with mean viral titers exceeding 4 ϫ 10 4 TCID 50 /ml (Fig. 8A) . Replicating virus remained detectable in 2 of the 5 animals to day 7 postinfection in nasal lavage fluid and pharyngeal swab samples. Trachea swab samples resulted in a low level of recovery of replicating virus, with only 2 of the 5 animals testing positive by TCID 50 assays (data not shown), but viral RNA was detected by RT-PCR in all trachea samples from H1N1-infected animals through day 3 postinfection (Fig. 8B) . Replicating virus was cleared from the nose and pharynx by day 9 postinfection, with low to undetectable levels of viral RNA being observed in lavage fluid and swab samples at this time point.
Body temperature was significantly different in H1N1-infected compared to mock-infected animals, with a mean of 103.1°F for H1N1-infected infants at day 3 postinfection (by two-way ANOVA for infection status and time) (Fig. 8C) . Increased body temperature was maintained in 2 H1N1-infected animals for 2 days despite treatment with acetaminophen. Clinical evaluation of animals by California National Primate Research Center staff veterinarians detected wheezing in 3 of 5 H1N1-infected animals at between days 2 and 7 postinfection.
Airway inflammation in H1N1-infected infant monkeys. There was a modest increase in upper airway inflammation in H1N1-infected animals, with a trend toward increased numbers of total leukocytes per ml recovered from nasal lavage fluids compared to mock-infected animals (P ϭ 0.056 for infection status by two-way ANOVA) (Fig. 9A) . Infection status accounted for 14.7% of the total variance in the nasal lavage fluid leukocyte counts. The phenotype of nasal lavage fluid leukocytes changed slightly during the evaluation period, with a significant influx of neutrophils (P ϭ Ͻ0.05 for time by two-way ANOVA) (Fig. 9B) . Time accounted for 35.8% of the total variance; however, there was no significant difference in neutrophil frequency between mock-and H1N1-infected animals. The frequency of lavage fluid monocytes was significantly increased over that for mock-infected animals (P ϭ Ͻ0.05 for infection status by two-way ANOVA) (Fig. 9C) . Lymphocyte frequencies in nasal lavage fluid were more variable and did not reach statistical significance at any infection time point , and H1N1-infected cultures were evaluated at 6 h (E and F) and 24 h (G and H) postinfection. Images were collected at a ϫ20 magnification. Bar ϭ 100 mm. (Fig. 9D ). Greater differences were observed in the compositions of inflammatory cells recovered from trachea swab samples of H1N1-and mock-infected animals, with significantly increased frequencies of macrophages, monocytes, and lymphocytes as a result of infection (P ϭ Ͻ0.05 for infection status by two-way ANOVA) (Fig. 9E, G, and H) . In trachea swab samples, the neutrophil frequency did not change as a result of infection status or time (Fig. 9F) . In the bronchoalveolar lavage fluid at day 14 postinfection, lymphocyte numbers appeared slightly elevated in H1N1-infected infants; however, only the numbers of monocytes were significantly increased over those in mock-infected animals (P Ͻ 0.05 by Student's t test) (Fig. 9I) . H1N1 infection did not significantly alter total white blood cell counts or change the proportion of neutrophils, lymphocytes, monocytes, or eosinophils in the peripheral blood ( Table 2) .
The airway and systemic proinflammatory cytokine responses following H1N1 infection were evaluated by ELISA and RT-PCR. There was a modest but not statistically significant increase in IFN-␣ protein levels in the nasal lavage fluid of H1N1-infected compared to mock-infected animals during the first few days of sampling, but this trend was reversed at later time points (Fig.  10A) . In serum, the induction of IFN-␣ protein in H1N1-infected compared to mock-infected infants did not reach statistical significance (Fig. 10B) . IFN-␣ mRNA levels were highly variable in peripheral blood and not consistently detected in nasal lavage fluid cell pellets regardless of infection status (data not shown). In contrast to the IFN-␣ response, IL-8 protein (Fig. 10C and D) and mRNA (data not shown) levels were reduced in both nasal lavage fluid and serum samples of H1N1-infected animals compared to mock-infected animals.
Recovery of the airways following clearance of infection was evaluated by histopathology of H&E-stained lung sections from mock-and H1N1-infected animals at 14 days postinfection. Lesions were scored on a scale from 1 to 4, with 1 being mild and 4 being severe (Table 3) . Four of the five H1N1-infected animals had a pulmonary lesion score of 2 or higher, with influenza virusinduced lung lesions centered on the terminal bronchioles. The mildest lesions had some expansion of the bronchiolar wall and the adjacent perivascular zone by an inflammatory cell infiltrate composed predominantly of macrophages and small lymphocytes, with fewer plasma cells and neutrophils (Fig. 11C) . In more severe lesions, inflammation extended out into the dependent alveoli. Alveolar septa were thickened by a mixed population of inflammatory cells, and alveolar spaces also contained inflammatory infiltrates, predominantly alveolar macrophages and a small number of neutrophils ( Fig. 11D and E) . In some areas, alveolar inflammation was accompanied by type II cell hyperplasia (Fig.  11F ). In regions with resolved inflammation, the alveolar septae remained prominent and thickened, and the alveoli were intermittently lined by type II pneumocytes or plump type I pneumo- cytes with rounded nuclei protruding into the alveolus. The mock-challenged animals did not have any significant pulmonary lesions, although there were scattered clusters of alveolar macrophages in some histology sections of the lungs (Fig. 11A and B) .
DISCUSSION
The immunological basis for the increased frequency and enhanced severity of respiratory virus infection observed in early life is poorly defined. To begin to investigate the immune mechanisms 
, where delta CT is the C T value of the gene of interest minus the mean C T value of housekeeping genes. The P value was determined based on a two-tailed t test of replicate 2 (Ϫdelta CT) values.
of influenza virus infection susceptibility during early childhood, we conducted comparative in vitro infections of infant and adult rhesus macaque airway epithelial cell cultures with pandemic H1N1. We also assessed whether infant rhesus monkeys could be infected in vivo by inoculation with pandemic H1N1. We focused on the contribution of airway epithelial cells as essential mediators of host defense. Our studies showed that infant airway epithelial cells supported higher levels of H1N1 replication for an extended period of time than their adult counterparts during infection at an MOI of 1 or 0.1 ( Fig. 1B and E) . Increased viral replication in infant cultures did not appear to be due to age-dependent differences in cell death, as markers of cellular viability and apoptosis were similar in H1N1-infected epithelial cells from both age groups (Fig. 1C and F and 3) . Variability in cell viability assays was noted for both infant and adult airway epithelial cells, which may reflect differences in plating efficiency during the initiation of primary cultures. Infant airway epithelial cells appeared to be capable of initiating an antiviral response at the transcriptional level, as evidenced by the observed increase in IFN-␣ and several type I IFN pathway gene mRNA levels at between 6 and 24 h in H1N1-infected cultures (Fig. 4A and 7) . However, there was a lack of IFN-␣ protein induction with H1N1 infection as well as with poly(I·C) treatment in infant cultures ( Fig.  4B and 6 ). It is important to consider that our current study was limited to IFN-␣, and with recent evidence suggesting a critical role for IFN-in the control of influenza A virus infections in respiratory epithelium (35, 36) , it will be important in the future to assess type III interferon in an age-dependent manner. Analysis of IL-8 in parallel did not reflect the age-dependent response of IFN-␣ (Fig. 4C and D) , indicating that the expression of all cytokines in response to virus is not universally regulated by chronological age.
Our results suggest the existence of an intrinsic developmental mechanism in infant airway epithelial cells that is responsible for attenuated IFN-␣ protein production following viral infection. Infant airway epithelial cells were capable of sensing virus via Tolllike receptor 3, as demonstrated by the induction of IL-8 mRNA and protein following poly(I·C) treatment (Fig. 6) . The observed attenuated IFN-␣ protein response in infant airway epithelial cells may be related to their sensitivity to the influenza virus-specific immune evasion and subversion properties reported previously for the influenza virus protein NS1 (37) . To further explore the type I IFN molecular pathways that distinguish infant airway epithelial cells from adult airway epithelial cells, we measured mRNA expression levels of 84 genes associated with IFN-␣ and -␤ signaling pathways in ALI cultures. In uninfected cells, the MAL level was significantly reduced by almost 6-fold in infant cultures relative to adult cultures. MAL encodes a proteolipid that has been shown to function in signaling, epithelial cell differentiation, and apical transport of proteins, including influenza virus hemagglutinin (38) (39) (40) (41) . More recent studies described MAL as a putative tumor suppressor gene with a role in promoting apoptosis (42) . The contribution of MAL to infant airway epithelial cell influenza virus susceptibility is unclear, and although its mRNA level was constitutively reduced in infant cultures, expression levels of MAL and several other type I IFN pathway genes were found to be increased at 24 h post-H1N1 infection (Fig. 7) . Comparatively, the majority of genes evaluated in this pathway were either unchanged or downregulated in adult cultures at this infection time point (Table 1; see also Tables S1 and S2 in  the supplemental material) .
Age-dependent differences in the host response to pandemic H1N1 in rhesus macaques and in ferrets have recently been reported. Josset et al. examined late-life immunity to influenza in aged rhesus monkeys, which is highly relevant to our pediatric studies, as a mirror-image pattern has been used by other investigators to describe immune function at the beginning and near the end of life (43) . Consistent with our observations of infant airway epithelium, aged rhesus monkeys showed increased viral loads and distinct innate immune responses to H1N1 compared to young adults (44) . In contrast, ferrets showed no significant ageassociated difference in H1N1 titers, although newly weaned ferrets had consistently higher viral loads than adult ferrets (45) . The viral replication discrepancy among these studies is potentially related to species-specific differences between ferrets and primates or may be due to the different pandemic H1N1 strains used. Nevertheless, newly weaned ferrets did show differential interferon responses to pandemic H1N1 compared to adult ferrets, which is consistent with our findings for airway epithelial cells derived from infant and adult monkeys.
Our study is the first to demonstrate pandemic H1N1 infection in infant rhesus monkeys; however, an important limitation is the lack of parallel in vivo studies in adult rhesus monkeys for direct comparison of susceptibility. Based upon previously reported findings for adult monkeys infected with either seasonal or pandemic H1N1 strains, peak viral titers in the nasal lavage fluid of H1N1-infected infants in this study appear to be 1 to 2 logs higher (46) (47) (48) (49) (50) . However, it should be emphasized that it is difficult to directly correlate parameters of infection and inflammation observed in this study with those of previous reports of adult rhesus monkeys based on differences in dose, inoculation methods, and sampling procedures. Surprisingly, unlike most influenza virus infection models, H1N1-infected infant monkeys showed only modest airway neutrophil infiltration associated with infection from days 1 to 3 (Fig. 9B and F) . Furthermore, the level of the neutrophil chemoattractant IL-8 remained low in nasal lavage fluid during infection (Fig. 10C ). Neutrophils were observed in nasal lavage fluid and trachea swab samples, where there was a statistically significant change over time in lavage fluid only, suggesting that the presence of this leukocyte phenotype may be due to repeated sampling, as mock-infected animals also showed signs of neutrophil influx in this compartment. A recent ferret study indicated that the lack of neutrophil lung recruitment in pan- demic H1N1 infection may be age related given the significantly reduced neutrophil-induced inflammatory response in newly weaned compared to adult ferrets (45) . An additional unexpected finding was the influx of monocytes into the upper airways early in infection and the marked increase in this leukocyte population in bronchoalveolar lavage fluid, which remained until day 14 postinfection (Fig. 9C , G, and I). The timing of monocyte appearance in the upper airways coincides with the decline of viral replication, suggesting that this population may contribute to the eradication of H1N1 and recovery of infant airways. Although we did not immunophenotype the monocytes in our model, these cells may be similar to a monocyte population recently identified in the nasal lavage fluid of influenza-infected pediatric patients, which was thought to suppress mucosal cytokine inflammation (51) . Recent reports suggest a higher pathogenic potential for pandemic than for seasonal H1N1. Most experimental infection models have evaluated lung histopathology at early time points, before viral clearance, and described pulmonary lesions as being more severe and prolonged than those associated with seasonal H1N1 strains (47, 50, 52) . Indeed, pulmonary inflammation was still present in our H1N1-infected infants 7 days after viral clearance. At day 14 postinfection, lesions were focused predominantly around terminal bronchioles, with extension into dependent alveoli (Fig. 11 ). In addition, there were histological lesions indicative of significant alveolar injury and repair in H1N1-infected animals. It is generally accepted that a subset of type II pneumocytes is able to proliferate in response to type I pneumocyte injury and then differentiate into type I cells to affect alveolar repair (53) . In addition, a population of airway stem cells was recently shown to contribute to alveolar regeneration following sublethal influenza virus infection in mice (54) . The alveolar injury in our model may be a direct effect of virus infection, as pandemic H1N1 has been shown to infect both type I and type II cells (47, 55, 56) . Alternatively, the observed epithelial cell injury may be caused by inflammation, as the cells in the terminal bronchioles and alveoli are specifically vulnerable to inflammation-induced injury. Regardless of the etiology, alveolar damage such as that detected in the H1N1-infected infant monkeys in this study may lead to secondary bacterial infection. These findings are consistent with epidemiologic data suggesting that influenza infection is more likely to progress to bronchiolitis and pneumonia in infant hosts (1, 2, 57) . However, comparative in vivo infections of adult rhesus monkeys with pandemic H1N1 will be necessary to fully understand the contribution of age to influenza pathogenicity.
Taken together, our data indicate that H1N1 viral replication is prolonged in infant airway epithelium and that secretion of IFN-␣ is attenuated relative to that of adults. Our experimental results support future mechanistic studies to identify adjunctive strategies capable of overcoming the immune deficits of the immature airway mucosa; this may ultimately translate into novel ap- proaches to enhance the efficacy of pediatric vaccines for respiratory pathogens.
